Description
| Specialty | ARAVEN |
|---|---|
| Dosage | 300 mg , 5 mg |
| Form | Film-coated tablet |
| Presentation | B/90 |
| Primary Packaging | Blister |
| Specification | Opaque white PVC/PVDC/ALU |
| INN / Active Ingredient | IRBESARTAN |
| VEIC Classification | Essential |
| Therapeutic Class | CARDIOVASCULAR SYSTEM |
| Subclass | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| Manufacturer / Laboratory | PHILADELPHIA PHARMA |
| Regulatory Category | A |
| Shelf Life | 24 months |
| Generic / Brand | Generic |
| Marketing Authorization (MA) Number | 9353046 |
| MA Date | 2014-08-12 |
| Product Range | Cardio-Metabolic Range |
Reviews
There are no reviews yet.